الرئيسية › دليل الباحثين › Rachid Malek
Rachid Malek
رشيد مالك(كتابة آلية)
الانتماء : University Ferhat Abbas of Setif · Centre Hospito Universitaire de Sétif
- 95منشورات (انتماء جزائري)
- 101مجموع المنشورات
- 1440الاستشهادات
- 16مؤشر h
الملف البحثي
لدى Rachid Malek 95 منشور(ات) مفهرسة (2008–2026). تُنشر أعماله أساسًا في «Médecine des Maladies Métaboliques»، «Diabetes Research and Clinical Practice» و«Diabetes & Metabolism». أكثر مقالاته استشهادًا هو «Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multin» (2013)، وقد استُشهد به 284 مرة. 15 من هذه المنشورات تعود إلى آخر ثلاث سنوات من النشاط. شارك في تأليف أعماله 12 باحثًا على الأقل، منهم باحثون من مؤسسات في اليابان، فرنسا.
هل هذا أنت؟ عرّف بأبحاثك
أنشئ ملفك على DzCademia مجانًا وأضف مقالاتك: ستظهر بسهولة أكبر على Google وفي مساعدي الذكاء الاصطناعي مثل ChatGPT، فيقرؤها ويستشهد بها عدد أكبر من الناس.
إنشاء ملفي المجاني إضافة منشوراتيمجالات البحث
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Education
- Dietary Effects on Health
المنشورات (95)
- Summary of Research: Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis
- A Summary of Cardiometabolic Disorders in the Maghreb: Insights from the 2025 Saclay Cardiometabolic Summit
- Faith-Based Diabetes Prevention: Lessons for the 57 OIC Member States
- Effect of Different Insulin Regimens on Individuals with Type 2 Diabetes during Ramadan Fasting in the DAR Global Surveys of 2020 and 2022
- Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review
- Correlation between Pre-Ramadan HbA1c Levels and Fasting Outcomes in Individuals with Type 2 Diabetes: Evidence from the Global 2020–2022 DAR Survey
- Impact of Albuminuria and Renal Function on Ramadan Fasting in Type 2 Diabetes
- Characteristics of Fasting in Ramadan in Type 2 Diabetes Patients on Empagliflozin in the DAR Global Surveys of 2020 and 2022
- Outcomes of People with Type 2 Diabetes using Sulfonylureas versus Other Non-Insulin Antidiabetic Agents during Ramadan: The Diabetes and Ramadan (DaR) Global Surveys
- Integrated image-based deep learning and language models for primary diabetes care
- An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022
- Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis
- Characteristics of non-fasting patients with diabetes type 2 in the DAR global surveys of 2020 and 2022
- L & Vous : enquête nationale pour évaluer l’utilisation de l’insuline basale chez les patients diabétiques de type 2 en Algérie
- Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire
- Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study
- Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey
- Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics
- Real-world Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Mellitus During the Period of Ramadan in Four Countries (Egypt, Jordan, Lebanon, and Turkey): A Prospective Observational Study
- Évaluation de la performance clinique et analytique du système de mesure de glycémie Vital Check® MM-1200/bandelettes MS-2 dans la vraie vie
- Review of: "Glycemic Control and Its Determinants Among Type 2 Diabetes Mellitus Patients at the Limbe Regional Hospital, Limbe, Southwestern Cameroon"
- Anévrismes artériels au cours de la maladie de Behçet : à propos de 20 cas dans une série de 501 patients
- Diabetes and Ramadan: Practical guidelines 2021
- Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort
- Characteristics and Treatment Patterns of Patients with Type 2 Diabetes Mellitus in the Middle East and Africa Cohort of the DISCOVER Study Program: a Prospective Study
- POSA38 Cost-Effectiveness Analysis of for Insulin Degludec (TRESIBA®) vs. Insulin Glargine U300 (TOUJEO®) in Algerian Setting
- IDF21-0686 Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM
- IDF21-0174 Prevalence and Risk Factors of Vascular Complications in Type 2 Diabetes: DISCOVER Study-Middle East and Africa Cohort
- Abstract #1305594: Real-Life Effectiveness and Care Patterns of Diabetes Management in Eastern Europe, Middle East, and Africa (RECAP-DM EEMEA STUDY)
- EE476 Budget Impact Analysis of iGlarLixi for Treatment of T2DM in Algerian Setting
- EE67 Cost Per Responder and Number Needed to Treat of iGlarlixi vs Premix BIAsp 30 in Algerian Setting
- The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes
- Prevalence of type 2 diabetes mellitus in Africa: an updated narrative review
- Real-World Safety and Effectiveness of iGlarLixi in People With Type 2 Diabetes who Fast During Ramadan: Results From Wave 1 of the SOLIRAM Study
- (Supplementary data) Prevalence of type 2 diabetes mellitus in Africa: an updated narrative review
- Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study
- Changes in fasting patterns during Ramadan, and associated clinical outcomes in adults with type 2 diabetes: A narrative review of epidemiological studies over the last 20 years
- Management of adult patients with type 1 diabetes mellitus in Africa
- Work-in-Progress: The Use of Big Data and Data Analytics in the Prevention, the Diagnosis and the Monitoring of Long-Term Diseases
- PDB37 Cost-Effectiveness of Insulin Degludec/Insulin Aspart Twice Daily Versus BASAL-Bolus Full Regimen in Patients with Type 2 Diabetes Mellitus in Algeria
- SUN-LB126 Real-World Safety and Effectiveness of Insulin Glargine 300 U/ML (Gla-300) in People With Type 2 Diabetes Who Fast During Ramadan
- Diabetes and Ramadan: A multicenter study in Algerian population
- Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region
- Résultats de l’International Diabetes Management Practices Study (IDMPS) Vague 7. Algérie
- PDB57 COST SAVINGS ASSOCIATED WITH PREMIX VERSUS BASAL-BOLUS REGIMEN IN ALGERIAN PATIENTS WITH TYPE 2 DIABETES INSUFFICIENTLY CONTROLLED UNDER BASAL INSULIN REGIMEN
- Transfert d’un schéma basal plus/basal-bolus vers un analogue d’une insuline prémix : rationnel et consensus
- Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
- Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp)
- Correction to: Multinational Consensus: Insulin Initiation with Insulin Degludec/Aspart (IDegAsp)
- Étude de comparaison de deux cohortes de patients algériens et caucasiens atteints de sclérodermie systémique
- Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan
- Corrélation entre l’hypoglycémie sévère et l’hypoglycémie non-sévère et les résultats psychologiques chez les personnes algériennes atteintes de diabète de type 1 et de type 2 : résultats de l’étude DAWN2™
- Living with an adult who has diabetes: Qualitative insights from the second Diabetes Attitudes, Wishes and Needs (DAWN2) study
- Des rires spasmodiques révélateurs d’une neurosarcoïdose !
- P274 Caractéristiques de l’obésité à Sétif
- P-113: Gangrene of feet on atherosclerosis complicating an arthritis rhumatoide
- Formation médicale continue (FMC) au diabète des médecins généralistes en Algérie, 2004-2014
- Analyse des raisons de suspension d’un traitement biologique
- P-114: Stroke and ischemic heart disease, therefore poisoning carbon monoxide
- An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetes
- Similar glucose control with basal–bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type 2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification
- P325 Facteurs associés à l’atteinte de l’objectif HbA1c chez des patients diabétiques de type 2 initiant un traitement par l’insuline détémir : résultats de l’étude A1chieve
- P313 Substitution d’un schéma d’injections multiples associant insuline glargine + insuline au moment des repas par un schéma insuline détémir + insuline asparte chez des patients diabétiques de type 2
- Relation entre auto-immunité thyroïdienne et auto-immunité pancréatique dans une population adulte de la ville de Constantine diagnostiquée cliniquement comme diabétique type 2
- Évaluation médico-économique à court et à long terme de l’initiation d’un traitement par l’insuline détemir chez des patients insulino-naïfs atteints de diabète de type 2
- Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study
- Safety and Effectiveness of Insulin Detemir in Different Age-Groups in the A1chieve Study
- Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A1chieve study
- Safety and effectiveness of insulin analogues in type 2 diabetic patients from Algeria: a sub-analysis of the A1chieve study
- Biphasic Insulin Aspart 30 in Insulin-Naive People with Type 2 Diabetes in Non-western Nations: Results from a Regional Comparative Multinational Observational Study (A 1 chieve)
- Dépistage de masse du diabète de type 2 en Algérie : quels enseignements ?
- Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes
- Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes
- Short and Long-Term Cost-Effectiveness of Switching Therapy from Insulin Glargine to Insulin Detemir in People with Type 2 Diabetes
- PO49 Dépistage de masse du diabète de type 2 en Algérie : quels enseignements ?
- Cardiomyopathies du lupus érythémateux systémique : une série de trois cas
- Fréquence de la thyroïdite autoimmune dans une série de diabétiques LADA de la ville de Constantine
- Influence of Retinopathy on Plasma Concentrations of total Homocysteine and other Biochemical Parameters in Algerian Patients with Type 2 Diabetes Mellitus
- Initiation de l’insuline détémir chez des patients diabétiques de type 2 insulino-naïfs en échec aux antidiabétiques oraux : étude de tolérance et d’efficacité en pratique courante en Algérie (Étude IDEALS)
- Risque accru d’auto-immunité thyroïdienne chez une population Constantinoise de diabétique type 2 à Ac antiGAD65 positif
- Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: Results from the A1chieve observational study
- DiabCare Algérie
- Épidémiologie du diabète en Algérie : revue des données, analyse et perspectives
- Prise en charge polyvalente du diabète
- DiabCare Algérie
- P5 L’infection par le virus de l’hépatite C prédispose au diabète de type 2
- P135 Impact de l’auto surveillance glycémique sur l’équilibre du diabète
- P217 Diabète gestationnel : résultats d’un dépistage systématique
- Association of hepatitis C virus infection and diabetes
- P208 Évaluation de l’HbA1c chez le diabétique de type 2
- Syndrome de Hughes-Stovin au cours de la maladie de Behçet : à propos de 7 cas
- Épidémiologie du diabète en Algérie : revue des données, analyse et perspectives
- P145 Profil bactériologique des lésions trophiques du pied diabétique et leur résistance aux antibiotiques
- P146 Lésions trophiques du pied diabétique. À propos de 236 cas
- P112 Évaluation de la prise en charge et du traitement du diabète de type 2 par les médecins généralistes
مجلات النشر
- Médecine des Maladies Métaboliques × 13
- Diabetes Research and Clinical Practice × 13
- Diabetes & Metabolism × 12
- Value in Health × 8
- La Revue de Médecine Interne × 6
- Journal of Diabetes and Endocrine Practice × 5
المنشورات حسب السنة
- 20263
- 20256
- 20246
- 20237
- 20229
- 20214
- 20206
- 20195
- 20184
- 20172
التعاون العلمي
المؤسسات الشريكة : Centre Hospitalo-Universitaire Dr Benbadis Constantine · University of Constantine 3 · University of Batna 1 · Badji Mokhtar-Annaba University · Hôpital Mustapha Pacha
بلدان المؤلفين المشاركين : اليابان · فرنسا
المؤلفون المشاركون
- F.Z. Mekideche
- Daoud Roula
- S. Hannat
- Alkassem Lezzar
- Nouria Benmostefa
- A. Nechadi
- Samir Rouabhia
- S.A. Hamma
- Nasim Nouri
- F. Mansouri
- S. Khettabi
- A. Lakehal
البيانات البيبليوغرافية مصدرها OpenAlex (قاعدة مفتوحة).
لماذا تختارون DzCademia؟
ملفات أكاديمية ومقالات ومداخلات علمية: امنحوا أبحاثكم حضوراً عاماً منظماً. تساعد البيانات الوصفية المدمجة محركات البحث ومساعدات الذكاء الاصطناعي على التعرف على أعمالكم وفهم مراجعها.
علّق عبر Google
سجّل الدخول عبر Google للتعليق مباشرة على هذه الصفحة.